Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Pneumonitis
ADR ID BADD_A03482
ADR Hierarchy
22      Respiratory, thoracic and mediastinal disorders
22.01      Lower respiratory tract disorders (excl obstruction and infection)
22.01.01      Lower respiratory tract inflammatory and immunologic conditions
22.01.01.006      Pneumonitis
Description A disorder characterized by inflammation focally or diffusely affecting the lung parenchyma. [CTCAE] Infection of the lung often accompanied by inflammation. | Inflammation of any part, segment or lobe, of the lung parenchyma. [MeSH]
MedDRA Code 10035742
MeSH ID D011014
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Pneumonitis | Pneumonitis NOS | Pulmonitis | Lung inflammation | Chronic pneumonitis | Obstructive pneumonitis | Noninfectious pneumonitis | Pneumonia | Pneumonias | Lobar Pneumonia | Lobar Pneumonias | Pneumonias, Lobar | Pneumonia, Lobar | Experimental Lung Inflammation | Experimental Lung Inflammations | Inflammation, Experimental Lung | Lung Inflammation, Experimental | Lung Inflammations, Experimental | Pneumonitides | Pulmonary Inflammation | Inflammation, Pulmonary | Inflammations, Pulmonary | Pulmonary Inflammations | Lung Inflammation | Inflammation, Lung | Inflammations, Lung | Lung Inflammations
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01506Muromonab-cd3--
BADD_D01508Mycophenolic acid0.001427%
BADD_D01576Nitrofurantoin--
BADD_D01581Nivolumab--
BADD_D01601Olaparib0.001925%
BADD_D01617Ondansetron0.000021%
BADD_D01629Osimertinib0.005720%
BADD_D01633Oxaliplatin0.000839%
BADD_D01637Oxcarbazepine0.000170%
BADD_D01653Paclitaxel0.003806%
BADD_D01654Palbociclib0.009469%
BADD_D01700Pembrolizumab--
BADD_D01701Pemetrexed0.000448%
BADD_D01803Porfimer sodium--
BADD_D01831Prednisolone0.000192%
BADD_D01834Prednisone0.000054%
BADD_D01847Procarbazine hydrochloride--
BADD_D01893Quinidine gluconate--
BADD_D01894Quinidine sulfate--
BADD_D01937Rifapentine--
BADD_D01970Rosiglitazone maleate--
BADD_D02026Simvastatin0.000018%
BADD_D02028Sirolimus0.000965%
BADD_D02029Sitagliptin0.000080%
BADD_D02058Sorafenib--
BADD_D02093Sulfasalazine0.000758%
BADD_D02097Sulindac--
BADD_D02100Sunitinib0.001175%
BADD_D02111Tamoxifen--
BADD_D02214Ticagrelor0.000870%
The 4th Page    First    Pre   4 5 6    Next   Last    Total 6 Pages